Tyratech Regulatory News (TYR)

TYRATECH, INC.

("TyraTech" or the "Company")

February, 2, 2012

Trading Update

TyraTech, Inc. (AIM: TYR), a natural life sciences company, today provides the following trading update to its shareholders.

Further to the Company's announcement on 11 January, the Company has continued to have positive discussions with Terminix regarding the current agreement and partnership between the two companies. Both companies recognise the strength of the relationship and are committed to continue working together for commercial success.

Terminix Vice President of Sales and Business Development, Stephen R. Good, said, "We are pleased with our renewed relationship with TyraTech and look forward to continued collaboration and innovation."

Based on the strength of the discussions and the partnership, the companies will continue to collaborate as envisioned to develop and commercialise innovative products that leverage TyraTech Nature's Technology® and the Terminix brand.

Shayne M. Wetherall, TyraTech's Vice President of Commercial Operations said, "We have enjoyed a strong and productive relationship with Terminix that continues to produce compelling and differentiated products. We look forward to continued collaboration, leveraging the power of our technology with the Terminix brand, to meet the growing demand for highly effective natural insect control solutions."

As per the announcement on 11 January, the Directors of the Company remain positive about the Company's medium and long-term prospects and are continuing to evaluate their funding options and will update the market on this as required.

For further information, please contact:

TyraTech Inc.

Alan Reade, Executive Chairman +1 919 415 4310

Peter Jerome, Chief Financial Officer +1 919 415 4280

N+1 Brewin (NOMAD & Broker)

Robert Beenstock +44 20 3201 3710